medigraphic.com
ISSN 2448-8909 (Print)

2017, Number 1

<< Back Next >>

Med Crit 2017; 31 (1)

Adipose tissue during critical illness and the obesity paradox

Vásquez-Revilla HR, Revilla-Rodríguez E

Language: Spanish
References: 27
Page: 36-41
PDF size: 161.71 Kb.


ABSTRACT

The term «obesity paradox» refers to the observations made in several clinical studies where a protective effect of obesity is demonstrated when it presents in the course of a critical illness. There are physiological bases that could explain this benefit, related to the metabolic activity and cellular changes that adipose tissue presents in critically ill patients with obesity. However, there is controversy as to whether changes are protective or only an adaptive response to the disease; it has been argued that there are factors that could contribute to have a wrong perception of this phenomenon, such as poor choice of the study design, a lack of scales to assess the severity in obese patients, nonspecific anthropometric measurements, among others. The aim of this paper is to review the available information on the role of adipose tissue during critical illness and obese patients in the ICU.


REFERENCES

  1. Slynkova K, Mannino D, Martin G, Morehead RS, Doherty DE. The role of body mass index and diabetes in the development of acute organ failure and subsequent mortality in an observational cohort. Crit Care. 2006;10(5):R137.

  2. Akinnusi ME, Pineda LA, El-Solh AA. Effect of obesity on intensive care morbidity and mortality: A meta-analysis. Crit Care Med. 2008;36:151-158.

  3. Hogue CW Jr., Stearns JD, Colantuoni E, Robinson KA, Stierer T, Mitter N, et al. The impact of obesity on outcomes after critical illness: a meta-analysis. Intensiv Care Med. 2009;35(7):1152-1170.

  4. Martino JL, Stapleton RD, Wang M, Day AG, Cahill NE, Dixon AE, et al. Extreme obesity and outcomes in critically ill patients. Chest. 2011;140:1198-1206.

  5. Pérez M. El adipocito como órgano endocrino. Implicaciones fisiológicas y terapéuticas. Rev Med. 2007;15:225-242.

  6. Gutiérrez J, Velásquez M, Prieto B. El tejido adiposo como órgano maestro en el metabolismo. Rev Endocrinol Nutr. 2011;19(4):154-162.

  7. Wade C. Adipose tissue alterations in critical illness: a paradox as to patient outcomes. Crit Care. 2013;17:188.

  8. Plank LD, Hill GL. Similarity of changes in body composition in intensive care patients following severe sepsis or major blunt injury. Ann N Y Acad Sci. 2000;904:592-602.

  9. Marques M, Perre S, Aertgeerts A, Derde S, Güiza F, Casaer MP, et al. Critical illness induces nutrient-independent adipogenesis and accumulation of alternatively activated tissue macrophages. Crit Care. 2013;17:R193.

  10. Flores J, Rodríguez E, Rivas S. Consecuencias metabólicas de la alteración funcional del tejido adiposo en el paciente con obesidad. Rev Med Hosp Gen Mex. 2011;74(3):157-165.

  11. Bornstein SR, Licinio J, Tauchnitz R, Engelmann L, Negrão AB, Gold P, et al. Plasma leptin levels are increased in survivors of acute sepsis: associated loss of diurnal rhythm, in cortisol and leptin secretion. J Clin Endocrinol Metab. 1998;83:280-283.

  12. Marques MB, Langouche L. Endocrine, metabolic and morphologic alterations of adipose tissue during critical illness. Crit Care Med. 2013;41(1):317-325.

  13. Nava C, Guerra A, Mendoza G, Flores A, Nava A. Las adipocinas como mediadores en la inflamación y el sistema inmune. Residente. 2013;8(3):97-105.

  14. Prins J. Adipose tissue as an endocrine organ. Best Prac Res Clin Endocrinol Metab. 2002;16(4):639-651.

  15. Teoh H, Quan A, Bang KW, Wang G, Lovren F, Vu V, et al. Adiponectin deficiency promotes endothelial activation and profoundly exacerbates sepsis-related mortality. Am J Physiol Endocrinol Metab. 2008;295(3):E658-664.

  16. López F, Cortés M. Obesidad y corazón. Rev Esp Cardiol. 2011;64(2):140-149.

  17. Vásquez H, Revilla E, Terrazas V. Mortalidad en el paciente críticamente enfermo con obesidad. Rev Asoc Mex Med Crit y Ter Int. 2015;29(2):93-98.

  18. El-Solh A, Sikka P, Bozkanat E, Jaafar W, Davies J. Morbid obesity in the medical ICU. Chest. 2001;120:1989-1997.

  19. Memtsoudis SG, Bombardieri AM, Ma Y, Walz JM, Chiu YL, Mazumdar M. Mortality of patients with respiratory insufficiency and adult respiratory distress syndrome after surgery: the obesity paradox. J Intensive Care Med. 2012;27(5):306-311.

  20. Oliveros H, Villamor E. Obesity and mortality in critically ill adults: a systematic review and meta-analysis. Obesity. 2008;16:515-521.

  21. Abhyankar S, Leishear K, Callaghan FM, Demner-Fushman D, McDonald CJ. Lower short- and long-term mortality associated with overweight and obesity in a large cohort study of adult intensive care unit patients. Crit Care. 2012;16(6):R235.

  22. Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, et al. Clinical characteristics, sepsis intervention and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013;17:R72.

  23. Wacharasint P, Boyd J, Russell J, Walley K. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013;17:R122.

  24. Rattan R, Nasraway SA Jr. Separating wheat from chaff: examining the obesity paradox in the critically ill. Crit Care. 2013;17:168.

  25. De Jong A, Jung B, Chanques G, Jaber S, Molinari N. Obesity and mortality in critically ill patiens. Another case of the simpson paradox? Chest. 2012;141(6):1637-1638.

  26. Venkatram S, Rapaka V, Anwer M, Diaz G. Body mass index have no effect in hospital mortality or intensive care outcomes in an inner city population. Int Med Inside. 2013; 1:1.

  27. Montejo J, Culebras J, García A. Recomendaciones para la valoración nutricional en el paciente crítico. Rev Med Chile. 2006;134:1049-1056.




2020     |     www.medigraphic.com